PRIMECAP Management (Trades, Portfolio) has recently increased its investment in Biogen Inc (NASDAQ:BIIB), a notable move that underscores the firm's confidence in the biotechnology company. The addition has adjusted PRIMECAP Management (Trades, Portfolio)'s position in Biogen Inc to 3.55% of its portfolio, representing an 11.22% stake in the company.